Granulysin

Current Opinion in Immunology

Volumn 15, Issue 5, 2003, Pages 560-565

  Clayberger, Carol ^a   Krensky, Alan M ^a  

^a STANFORD UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIAL PROTEIN; GRANULYSIN; HYDROLASE; LUNG SURFACTANT; RNA; SPHINGOLIPID ACTIVATOR PROTEIN; SPHINGOMYELIN PHOSPHODIESTERASE; SURFACTANT PROTEIN B;

BACTERIAL INFECTION; CORRELATION ANALYSIS; CRYSTAL STRUCTURE; CYTOTOXIC T LYMPHOCYTE; DISEASE ASSOCIATION; DNA MICROARRAY; DRUG POTENCY; HISTOCOMPATIBILITY; HOST RESISTANCE; HUMAN; IMMUNE RESPONSE; IMMUNOMODULATION; LEPROSY; MICROBIAL IMMUNITY; MYCOBACTERIUM LEPRAE; MYCOBACTERIUM TUBERCULOSIS; NATURAL KILLER CELL; NONHUMAN; ORGAN TRANSPLANTATION; PROTEIN DETERMINATION; PROTEIN EXPRESSION; PROTEIN FAMILY; PROTEIN FUNCTION; PROTEIN STRUCTURE; REVIEW; SEQUENCE HOMOLOGY; STATISTICAL SIGNIFICANCE; T LYMPHOCYTE ACTIVATION; TUMOR CELL DESTRUCTION; TUMOR IMMUNITY;

EID: 0141853014     PISSN: 09527915     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0952-7915(03)00097-9     Document Type: Review

References (37)

1. Pena S.V., Krensky A.M. Granulysin, a new human cytolytic granule-associated protein with possible involvement in cell-mediated cytotoxicity. Semin. Immunol. 9:1997;117-125.
2. Pena S.V., Hanson D.A., Carr B.A., Goralski T.J., Krensky A.M. Processing, subcellular localization, and function of 519 (granulysin), a human late T cell activation molecule with homology to small, lytic, granule proteins. J. Immunol. 158:1997;2680-2688.
3. Jongstra J., Schall T.J., Dyer B.J., Clayberger C., Jorgensen J., Davis M.M., Krensky A.M. The isolation and sequence of a novel gene from a human functional T cell line. J. Exp. Med. 165:1987;601-614.
4. Gamen S., Hanson D.A., Kaspar A., Naval J., Krensky A.M., Anel A. Granulysin-induced apoptosis. I. Involvement of at least two distinct pathways. J. Immunol. 161:1998;1758-1764.
5. Hanson D.A., Kaspar A.A., Poulain F.R., Krensky A.M. Biosynthesis of granulysin, a novel cytolytic molecule. Mol. Immunol. 36:1999;413-422.
6. Stenger S., Hanson D.A., Teitelbaum R., Dewan P., Niazi K.R., Froelich C.J., Ganz T., Thoma-Uszynski S., Melian A., Bogdan C.et al. An antimicrobial activity of cytolytic T cells mediated by granulysin. Science. 282:1998;121-125.
7. Munford R.S., Sheppard P.O., O'Hara P.J. Saposin-like proteins (SAPLIP) carry out diverse functions on a common backbone structure. J. Lipid Res. 36:1995;1653-1663.
8. Anderson D.H., Sawaya M.R., Cascio D., Ernst W., Modlin R., Krensky A., Eisenberg D. Granulysin crystal structure and a structure-derived lytic mechanism. J. Mol. Biol. 325:2003;355-365 The crystal structure of granulysin indicates that it folds similar to other saposin family members and suggests that binding to the cell surface facilitates a scissors motion tunneling granulysin into the fracturing target membrane.
9. Hamamoto K., Kida Y., Zhang Y., Shimizu T., Kuwano K. Antimicrobial activity and stability to proteolysis of small linear cationic peptides with D-amino acid substitutions. Microbiol. Immunol. 46:2002;741-749.
10. Andreu D., Carreno C., Linde C., Boman H.G., Andersson M. Identification of an anti-mycobacterial domain in NK-lysin and granulysin. Biochem. J. 344:1999;845-849.
11. Wang Z., Choice E., Kaspar A., Hanson D., Okada S., Lyu S.C., Krensky A.M., Clayberger C. Bactericidal and tumoricidal activities of synthetic peptides derived from granulysin. J. Immunol. 165:2000;1486-1490.
12. Ernst W.A., Thoma-Uszynski S., Teitelbaum R., Ko C., Hanson D.A., Clayberger C., Krensky A.M., Leippe M., Bloom B.R., Ganz T.et al. Granulysin, a T cell product, kills bacteria by altering membrane permeability. J. Immunol. 165:2000;7102-7108.
13. Obata-Onai A., Hashimoto S., Onai N., Kurachi M., Nagai S., Shizuno K., Nagahata T., Mathushima K. Comprehensive gene expression analysis of human NK cells and CD8(+) T lymphocytes. Int. Immunol. 14:2002;1085-1098.
14. Mincheva-Nilsson L., Nagaeva O., Sundqvist K.G., Hammarstrom M.L., Hammarstrom S., Baranov V. Gammadelta T cells of human early pregnancy decidua: evidence for cytotoxic potency. Int. Immunol. 12:2000;585-596.
15. Spada F.M., Grant E.P., Peters P.J., Sugita M., Melian A., Leslie D.S., Lee H.K., van Donselaar E., Hanson D.A., Krensky A.M.et al. Self-recognition of CD1 by gamma/delta T cells: implications for innate immunity. J. Exp. Med. 191:2000;937-948.
16. Dieli F., Troye-Blomberg M., Ivanyi J., Fournie J.J., Krensky A.M., Bonneville M., Peyrat M.A., Caccamo N., Sireci G., Salerno A. Granulysin-dependent killing of intracellular and extracellular Mycobacterium tuberculosis by Vgamma9/Vdelta2 T lymphocytes. J. Infect. Dis. 184:2001;1082-1085.
17. Stenger S., Rosat J.P., Bloom B.R., Krensky A.M., Modlin R.L. Granulysin: a lethal weapon of cytolytic T cells. Immunol. Today. 20:1999;390-394.
18. Stenger S. Cytolytic T cells in the immune response to Mycobacterium tuberculosis. Scand. J. Infect. Dis. 33:2001;483-487.
19. Kitamura N., Koshiba M., Horie O., Ryo R. Expression of granulysin mRNA in the human megakaryoblastic leukemia cell line CMK. Acta Haematol. 108:2002;13-18.
20. Kida Y., Shimizu T., Kuwano K. Opposing roles of activator protein-1 and CCAAT/enhancer binding protein beta in the regulation of inducible granulysin gene expression in a human monocytic cell line, THP-1. Immunology. 107:2002;507-516.
21. Kaspar A.A., Okada S., Kumar J., Poulain F.R., Drouvalakis K.A., Kelekar A., Hanson D.A., Kluck R.M., Hitoshi Y., Johnson D.E.et al. A distinct pathway of cell-mediated apoptosis initiated by granulysin. J. Immunol. 167:2001;350-356.
22. Pardo J., Perez-Galan P., Gamen S., Marzo I., Monleon I., Kaspar A.A., Susin S.A., Kroemer G., Krensky A.M., Naval J.et al. A role of the mitochondrial apoptosis-inducing factor in granulysin-induced apoptosis. J. Immunol. 167:2001;1222-1229.
23. + T cells. This is the first demonstration that silencing granulysin gene expression in intact cells abrogates target cell lysis.
24. Canaday D.H., Wilkinson R.J., Li Q., Harding C.V., Silver R.F., Boom W.H. CD4(+) and CD8(+) T cells kill intracellular Mycobacterium tuberculosis by a perforin and Fas/Fas ligand-independent mechanism. J. Immunol. 167:2001;2734-2742.
25. Dieli F., Sireci G., Caccamo N., Di Sano C., Titone L., Romano A., Di Carlo P., Barera A., Accardo-Palumbo A., Krensky A.M.et al. Selective depression of interferon-gamma and granulysin production with increase of proliferative response by Vgamma9/Vdelta2 T cells in children with tuberculosis. J. Infect. Dis. 186:2002;1835-1839.
26. Ochoa M.T., Stenger S., Sieling P.A., Thoma-Uszynski S., Sabet S., Cho S., Krensky A.M., Rollinghoff M., Nunes Sarno E., Burdick A.E.et al. T-cell release of granulysin contributes to host defense in leprosy. Nat. Med. 7:2001;174-179.
27. Ochoa M.T., Thoma-Uszynski S., Sieling P.A., Sabet S., Cho S., Krensky A.M., Burdick A., Rea T.H., Modlin R.L. Role of granulysin in immunity to leprosy. Lepr. Rev. 71(Suppl.):2000;S115-S116.
28. Kida Y., Kuwano K., Zhang Y., Arai S. Acholeplasma laidlawii up-regulates granulysin gene expression via transcription factor activator protein-1 in a human monocytic cell line, THP-1. Immunology. 104:2001;324-332.
29. Hata A., Zerboni L., Sommer M., Kaspar A.A., Clayberger C., Krensky A.M., Arvin A.M. Granulysin blocks replication of varicella-zoster virus and triggers apoptosis of infected cells. Viral. Immunol. 14:2001;125-133.
30. Lehrer R.I., Ganz T. Antimicrobial peptides in mammalian and insect host defence. Curr. Opin. Immunol. 11:1999;23-27.
31. Smyth M.J., Kelly J.M., Sutton V.R., Davis J.E., Browne K.A., Sayers T.J., Trapani J.A. Unlocking the secrets of cytotoxic granule proteins. J. Leukoc. Biol. 70:2001;18-29.
32. Mackewicz C.E., Ridha S., Levy J.A. HIV virions and HIV replication are unaffected by granulysin. AIDS. 14:2000;328-330.
33. Kishi A., Takamori Y., Ogawa K., Takano S., Tomita S., Tanigawa M., Niman M., Kishida T., Fujita S. Differential expression of granulysin and perforin by NK cells in cancer patients and correlation of impaired granulysin expression with progression of cancer. Cancer Immunol. Immunother. 50:2002;604-614 Examination of granulysin and perforin expression in NK cells from cancer patients and healthy controls revealed that tumor-free cancer patients and healthy controls exhibited equally high levels of granulysin and perforin, although tumor-bearing cancer patients expressed remarkably lower levels of granulysin, but not perforin. They conclude that impaired expression of granulysin correlates with progression of cancer.
34. Sekiya M., Ohwada A., Katae M., Dambara T., Nagaoka I., Fukuchi Y. Adenovirus vector-mediated transfer of 9 kDa granulysin induces DNA fragmentation in HuD antigen-expressing small cell lung cancer murine model cells. Respirology. 7:2002;29-35 Adenovirus vector-mediated transfer of 9 kDa granulysin into an adenocarcinoma cell line suppressed cell growth and increased DNA fragmentation.
35. Sarwal M.M., Jani A., Chang S., Huie P., Wang Z., Salvatierra O. Jr., Clayberger C., Sibley R., Krensky A.M., Pavlakis M. Granulysin expression is a marker for acute rejection and steroid resistance in human renal transplantation. Hum. Immunol. 62:2001;21-31.
36. Soccal P.M., Doyle R.L., Jani A., Chang S., Akindipe O.A., Poirier C., Pavlakis M. Quantification of cytotoxic T-cell gene transcripts in human lung transplantation. Transplantation. 69:2000;1923-1927.
37. Ericson K.G., Fadeel B., Andersson M., Gudmundsson G.H., Gurgey A., Yalman N., Janka G., Nordenskjold M., Henter J.I. Sequence analysis of the granulysin and granzyme B genes in familial hemophagocytic lymphohistiocytosis. Hum. Genet. 112:2003;98-99.